The Cooper Companies, Inc. $COO Stock Position Decreased by Macquarie Group Ltd.

Macquarie Group Ltd. cut its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 64.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 513,396 shares of the medical device company’s stock after selling 933,497 shares during the quarter. Macquarie Group Ltd.’s holdings in Cooper Companies were worth $42,078,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of COO. Root Financial Partners LLC boosted its stake in shares of Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after acquiring an additional 162 shares in the last quarter. Bell Investment Advisors Inc boosted its stake in shares of Cooper Companies by 106.3% during the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after acquiring an additional 219 shares in the last quarter. CYBER HORNET ETFs LLC bought a new stake in shares of Cooper Companies during the 2nd quarter worth $36,000. True Wealth Design LLC boosted its stake in shares of Cooper Companies by 484.8% during the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after acquiring an additional 383 shares in the last quarter. Finally, Cromwell Holdings LLC boosted its stake in shares of Cooper Companies by 128.8% during the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after acquiring an additional 273 shares in the last quarter. 24.39% of the stock is owned by institutional investors.

Cooper Companies Price Performance

COO opened at $67.88 on Friday. The stock has a fifty day moving average of $64.79 and a 200-day moving average of $74.35. The firm has a market capitalization of $13.24 billion, a P/E ratio of 57.53, a PEG ratio of 1.77 and a beta of 0.87. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on COO shares. Piper Sandler set a $86.00 price objective on Cooper Companies and gave the stock an “overweight” rating in a research note on Monday, June 1st. Rothschild & Co Redburn lowered Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price for the company. in a report on Wednesday, March 4th. Barclays increased their target price on Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, March 6th. BNP Paribas Exane reduced their target price on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a report on Monday, June 8th. Finally, Robert W. Baird reduced their target price on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a report on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, five have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $82.64.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.